Glimepiride Tablets

Glimepiride Tablets is a sulfonylurea hypoglycemic drug that can be used in
combination with insulin. In 2001, Glimepiride tablets (Dibei), as the first
hypoglycemic product of Beilu Pharma, was first listed in China and belongs to
the second class of national new drugs.

Product name: Glimepiride Tablets
Specifications: glimepiride 1 mg×30 tablets；glimepiride 2 mg×15 tablets；
glimepiride 2mg×30 tablets

Characteristics: White tablet

Indications :

As one of the oral antidiabetic drugs produced by Beilu Pharma, our glimepiride
tablets are only suitable for type 2 diabetes that cannot fully control blood
sugar through diet control, exercise therapy and weight loss.

Glimepiride tablets are not suitable for type 1 diabetes (for example, the
treatment of diabetic patients with a history of ketoacidosis), diabetic
ketoacidosis or Treatment of pre-diabetic coma or coma.

Usage and Dosage: Please refer to the package insert

Adverse reactions, Contraindications, Precautions: Please refer to the package
insert.

Storage: Shade, seal, and keep in a dry place.

Packaging: Aluminum plastic packaging, 15 pills/plate, 1 plate/box; 15
pills/plate, 2 plates/box.

Shelf life: 24 months

Advantages of Glimepiride Tablets
Double effect directly hit the hypoglycemic core

Double effect: Glimepiride tablets can promote insulin secretion and improve
insulin resistance. At the same time, it can improve the two major
pathophysiological abnormalities of insulin secretion and insulin resistance in
patients with type 2 diabetes.

Efficiently reduce postprandial blood glucose, fasting blood glucose and
glycosylated haemoglobin

Glimepiride tablets monotherapy can comprehensively reduce FPG PPG and HbA1c in
newly diagnosed T2DM patients

Combination therapy, such as combined metformin, acarbose, etc., has a more
significant overall hypoglycemic effect

Less hypoglycemia, less weight impact, high safety

Short-term treatment, the risk of glimepiride hypoglycemia is only 1/3 of that
of Glibenclamide

Long-term treatment, the risk of glimepiride hypoglycemia is only 1/7of that of
Glibenclamide

Glimepiride has a small impact on the weight of T2DM patients

Once a day to improve patient compliance

If the patient's compliance is poor, Glimepiride tablets should be selected,
once a day.

Beilu is a professional contrast media manufacturing companies, we provide
gadolinium contrast media, glimepiride 2mg tablets, glimepiride package insert
and etc. Want to know more? Please contact us.

Minimum Order: 20 bags

Click to Enlarge